ZSZahra Shiravani

Zahra Shiravani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zahra Shiravani has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Exploring Probiotics as an Effective Treatment for Vaginitis: A Systematic Review

    by Zahra Shiravani, Sima Kamkari

    Introduction: Extended use of vaginal medications can disrupt the natural balance of the vaginal microbiota. In recent years, probiotics have emerged as a promising therapeutic approach. The objective of this review is to assess the effectiveness of probiotics in the treatment of vaginitis. Methods: For this review, articles published between 2008 and 2025 were retrieved from the PubMed, Scopus, and Google Scholar databases. The search was conducted using keywords such as "probiotics," "vaginitis," "treatment," and "vaginal flora." Studies examining the effects of probiotics on various types of vaginitis were analyzed. Results: Several probiotics, particularly Lactobacillus strains, have been identified as effective treatments for vaginitis. Research indicates that strains such as Lactobacillus rhamnosus GR-1, Lactobacillus reuteri RC-14, Lactobacillus crispatus, and Lactobacillus gasseri can reduce symptoms of bacterial vaginosis (BV) and prevent recurrence. Furthermore, when used in conjunction with antibiotics, probiotics have demonstrated significant therapeutic and preventive effects against vaginal infections, notably BV and vaginal candidiasis (VVC). Conclusion: Probiotic therapy represents a safe and effective treatment option for vaginitis, particularly in cases caused by bacterial and fungal infections. It can serve as a complementary treatment to conventional therapies. Numerous studies suggest that probiotics, especially Lactobacillus strains, play a crucial role in restoring the vaginal microbiota and alleviating symptoms, while also preventing recurrent infections.

  • Open Access

    Bladder hydrodissection vs. Traditional hysterectomy in placenta accreta: a single-center controlled trial pilot study in Shiraz, Iran

    by Shaghayegh Moradi Alamdarloo, Atefe Hashemi, Hamide Barzegar, Zahra Ovaisi, Elham Askary, Homeira Vafaei, Nasrin Asadi, MohammadHossein Anbardar, Zahra Shiravani

    Placenta accreta is a serious condition during pregnancy often leading to cesarean hysterectomy. This study aimed to investigate a novel hysterectomy metho


  • Open Access

    Survival Rates and Prognostic Factors Among Patients with Endometrial Cancer

    by Zahra Shiravani, Fatemeh Sadat Najib, Sima Kamkari, Samaneh Bahrami

    Background: The assessment of patient survival outcomes in endometrial cancer (EC) is of paramount importance in evaluating the efficacy of its comprehensive management strategy. Objectives: This investigation aims at appraising overall survival (OS) and disease-free survival (DFS) in EC patients and elucidating prognostic factors that influence their long-term survival prospects. Methods: In this retrospective cohort study, medical records of patients with definitively diagnosed uterine EC referred to Shiraz Motahari Tumor Clinic from 2014 to 2018 were reviewed. Baseline demographic, pathological, clinical data, tumor characteristics, and outcome data were collected from the patients' medical records. Kaplan-Meier method and multivariate Cox regression were used to analyze factors and predictors of OS and PFS. Results: The estimated probabilities of 1, 3, and 5 years DFS were 93%, 90%, and 88%, respectively, and OS were 92%, 89%, and 89 % respectively. The mean age ± SD of patients was 57.67 ± 7.94 years, and 97.2% were married. The mean number of deliveries was 2.74 ± 1.63. Invasiveness features showed involvement of cervix stroma (12.8%), myometrium (lower than 50% was 70%, and more than 50% was 30%), lymphovascular invasion (LVI) (1.9%), adenex (5.30%), and lymph node (1.7%). Stage 1A, 1B, stage 2, stage 3A, stage 3C, and stage 4 were observed in 78.9%, 8.6%, 8.6%, 1.9%, 0.3%, and 1.7% of patients, respectively. Endometrioid carcinoma was the predominant type, accounting for 93.3% of cases (334), followed by papillary serous carcinoma (5.6%) (n = 20). Clear cell carcinoma was relatively uncommon (n = 4, 1.1%). At diagnosis, 29.5% of patients were grade 3, 21.5% were stage 3, and 12.0% were IV. The median minimum and maximum tumor sizes were 4.0 (> 0 - 12) cm. Cytopathology was positive in 1.1% of patients, and 68.6% of patients needed no second treatment, 5.8 % were treated using chemoradiation, 13.6% with brachytherapy, 0.8% with EBRT/brachytherapy, and 11.10% were treated with Brachytherapy/chemoradiation. Conclusions: International Federation of Gynecology and Obstetrics (FIGO) stages, tumor grade, marital status, lymph vascular invasion, deliveries, and age group of patients have been identified as predictors of survival. Early detection of EC enables optimal surgery.


  • Open Access

    Human Papillomavirus Prevalence in Urine and Anatomical Sites in South Iranian Men and Women with Normal and External Genital Warts: A Cross-Sectional Study

    by Nasrin Aliabadi, Nahid Heydari Marandi, Gholamreza Pouladfar, Marzieh Hosseini, Zahra Shiravani, Marzieh Jamalidoust, Naeimehossadat Asmarian, Ali Faramarzi, Hossain Faramarzi, Mazyar Ziyaeyan

    Background: Human papillomavirus (HPV) is the most prevalent sexually transmitted infection, especially among sexually active individuals. Objectives: This study aimed to determine the prevalence of HPV infection among males and females in Southern Iran. Although previous studies have explored HPV prevalence in various provinces across Iran, this research is unique as the first to examine a four-type sample within this region. Methods: This cross-sectional study involved a sample of residents from Southern Iran, comprising 82 females (71.9%) and 32 males (28.1%), aged between 13 and 74 years, most of whom were sexually active. The main focus of the research was to investigate HPV infection across various anatomical sites in both healthy women and those with external genital warts (eGW). Results: The anatomical sites assessed included the oral, anal, vaginal, and urinary areas. Out of the total sample, 79 individuals (69.3%) tested positive for HPV. Within this group, 65 individuals (81.3%) were from the eGW group, while 14 individuals (41.2%) belonged to the normal population. A statistically significant difference (P ≤ 0.1) was observed in the prevalence of HPV in oral samples between the two groups. In the eGW group, 61 participants were positive for low-risk HPV (LR-HPV) genotypes, and 4 tested positive for HPV-18. Among the normal population, 14 individuals tested positive for LR-HPV genotypes. Notably, a higher proportion of positive HPV results—approximately 29%—was identified in anal and urinary samples compared to vaginal samples from females in the normal population. Conclusions: Significant differences in HPV prevalence were noted between individuals with eGW and those in the normal population. Overall, the prevalence of HPV among eGW individuals was approximately twice that of the normal population across the four anatomical sites. Further research is warranted to better understand the association between HPV infection, eGW, and various sociodemographic factors.

  • Open Access

    Investigation of PD-1 gene variants in patients with endometrial cancer: A case-control study

    by Mohammad Javad Fattahi, Mozhdeh Momtahan, Maryam Poostkar, Zahra Shiravani, Nasrollah Erfani, Mohammad Reza Haghshenas, Masoumeh Hashemi, Abbas Ghaderi, Ali Kashkooe

    Objective: To assess the possible association of two single -nucleotide polymorphisms (SNPs), PD -1.3 (+7146G/A) and PD -1.5 (+7785C/T), with endometrial cancer (EC) susceptibility. In addition, the correlations between these SNPs and available clinicopathologic characteristics of patients with EC were investigated. Materials and Methods: In this case -control study, 147 women with pathologically confirmed EC and 258 age- and ethnically matched healthy women were enrolled between June 2019 and May 2022. Genomic DNA was extracted, and genotyping of PD -1.3 (+7146G/A) and PD -1.5 (+7785C/T) SNPs was performed. Haplotype analysis was also performed. Pearson's chi-square test with Yates correction was used to evaluate differences in allele and genotype distributions. The 95% confidence interval and odds ratio were determined using an unconditional logistic regression model. Results: There were no remarkable differences in the allele and genotype distributions of PD -1.3 (rs11568821) and PD -1.5 (rs2227981) between healthy controls and EC patients. However, there was a remarkable difference in the AC haplotype between the control and EC groups. No association was found between the investigated SNPs and the clinicopathologic features of EC. Conclusion: Our results indicated that the aforementioned SNPs were not related to the risk of EC in the southern Iranian population.


  • Economic burden of cervical cancer and premalignant lesions associated with human papilloma virus: a societal perspective

    by Farhad Lotfi, Fatemeh Khodabandeh, Abdosaleh Jafari, Mehdi Rezaee, Hamed Rahimi, Zahra Shiravani, Khosro Keshavarz

    Cervical cancer is one of the most common cancers in women, the cause of which is mostly human papilloma virus (HPV). The aim of this study was to determine the economic burden of cervical cancer a...


  • Open Access

    Evaluation of Clinicopathologic Factors and Surgery Management on Borderline Ovarian Tumor Outcomes

    by Zahra Shiravani, Niloofar Namazi, Masooumeh Hashemi, Fateme Sadat Najib, Mojgan Hajisafari Tafti

    Background: Borderline ovarian tumor (BOT) is a tumor most prevalent in young woman with desire to fertility. There are some controversies on the patient characteristic besides to the factors affecting the recurrence rate among different races. Objectives: The aim of this study is to evaluate clinicopathologic features of the tumor to discover the controversies on the topic. Methods: Medical data of the all referred patients to Motahari clinic from January 2010 till October 2020 were recorded. Patient clinicopathologic characteristics affecting on outcome were evaluated. By using SPSS software, data were tested by chi-square and fish exact test. Also, log rank test was used for survival analysis Results: Totally 145 patients were enrolled. 61.4% versus 38.6% of the patients underwent fertility sparing surgery and radical surgery respectively with common characteristics of mostly belong to stage 1A disease (61.8% vs. 66.1%), unilateral (93.3% vs. 89.3%), serous histology (51.7% vs. 66.1%). The characteristics were different in the aspects of age and tumor size. In the aspect of recurrence rate, higher FIGO stage, younger age, tumor size less than 10cm, performing laparoscopy and fertility sparing surgery were with higher rate of recurrence (P-value < 0.05) while histology type of the tumor, lateralization, micropapillary, microinvasion, noninvasive peritoneal implants, receiving adjuvant chemotherapy and performing lymphadenectomy were not statistically significant for recurrence (P-value > 0.05). Two patients had malignant transformation. Conclusions: Fertility sparing surgery was with more recurrence rate in borderline ovarian tumor patients. However, micropapillary, microinvasion were not significantly with higher recurrence rate in our study but they are challenging issues in border line ovarian tumors among different studies. Due to most prevalence of border line ovarian tumors in young women and desire of fertility preservation, we should notice more to clinicopathologic and surgery types affecting on recurrence of BOTs.


  • Open Access

    A Case of Persistent Intrauterine Molar Pregnancy with Final Diagnosis of Heterotopic Molar Pregnancy: A Very Rare Entity

    by Zahra Shiravani, Fateme Sadat Najib, Mojgan Akbarzadeh-Jahromi, Mojgan Hajisafari Tafti

    Introduction: Gestational trophoblastic disease (GTD) includes hydatiform mole, choriocarcinoma, placental site trophoblastic tumor, and epithelial trophoblastic tumor. Also, molar pregnancy can happen as an ectopic pregnancy. The coincidence of these complicated pregnancies seems to occur extremely rarely. Case presentation: Here, we presented a 26-year-old woman, nulli gravida with the first presentation of intrauterine complete molar pregnancy; she underwent suction curettage but was prompted to Gestational Trophoblastic Neoplasm (GTN) and she received chemotherapy. During chemotherapy, she had severe abdominal pain and underwent laparotomy, and found an ectopic molar pregnancy in the fallopian tube. Salpingectomy was done and followed up with serum human chorionic gonadotropin (hCG) level and again due to improper decrease of hCG levels, she was diagnosed as a heterotopic post-molar GTN and received methotrexate (MTX) in multiple doses, but she did not respond to MTX, so we started actionomycine-D (Act-D) for her. She was cured after receiving 5 courses of Act-D and now she is on her monthly follow-up with an hCG level. Conclusions: It is important to notice the likelihood of ectopic molar pregnancy or a heterotopic molar pregnancy in the case of managing molar pregnancy, especially when we encounter a case’s poor response to medical or surgical therapy.


  • Open Access

    Effectiveness of pentoxifylline in severe early-onset fetal growth restriction: A randomized double-blinded clinical trial

    by Nasrin Asadi, Shohreh Roozmeh, Homeira Vafaei, Naeimehossadat Asmarian, Akram Jamshidzadeh, Khadije Bazrafshan, Maryam Kasraeian, Azam Faraji, Zahra Shiravani, Ali Mokhtar pour, et al.


  • Open Access

    Does Vitex Agnus-Castus L. Have Deleterious Effect on Fertility and Pregnancy Outcome? An Experimental Study on Rats for Prediction of Its Safety

    by Fateme Sadat Najib, Tahereh Poordast, Monireh Sufi Mahmudi, Zahra Shiravani, Niloofar Namazi, Gholamhossein Ranjbar Omrani

    Fateme Sadat Najib, Tahereh Poordast, Monireh Sufi Mahmudi, Zahra Shiravani, Niloofar Namazi, Gholamhossein Ranjbar Omrani. J Pharmacopuncture 2022;25:106-13. https://doi.org/10.3831/KPI.2022.25.2.106